Correlation Between Milestone Pharmaceuticals and RenovoRx
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and RenovoRx, you can compare the effects of market volatilities on Milestone Pharmaceuticals and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and RenovoRx.
Diversification Opportunities for Milestone Pharmaceuticals and RenovoRx
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and RenovoRx is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and RenovoRx go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and RenovoRx
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.32 times less return on investment than RenovoRx. In addition to that, Milestone Pharmaceuticals is 1.0 times more volatile than RenovoRx. It trades about 0.28 of its total potential returns per unit of risk. RenovoRx is currently generating about 0.37 per unit of volatility. If you would invest 98.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 38.00 from holding RenovoRx or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. RenovoRx
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| RenovoRx |
Milestone Pharmaceuticals and RenovoRx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and RenovoRx
The main advantage of trading using opposite Milestone Pharmaceuticals and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.The idea behind Milestone Pharmaceuticals and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |